Archive for December, 2008

Business Wire - Corixa and GlaxoSmithKline Respond to FDA; Complete Review Letter for BEXXAR

Thursday, December 11th, 2008

Business Editors & Health/Medical Writers
BIOWIRE2K
SEATTLE & PHILADELPHIA–(BW HealthWire)–March 25, 2002
Corixa Corporation (Nasdaq:CRXA) and GlaxoSmithKline (NYSE:GSK), today announced that Corixa has notified th…

FDA Requests Boxed Warnings on Older Class of Antipsychotic Drugs

Wednesday, December 10th, 2008

ROCKVILLE, Md., June 16, 2008–The U.S. Food and Drug
Administration today exercised its new authority under the Food and
Drug Administration Amendments Act of 2007 (FDAAA) to require
manufacturers of “conventional” antipsychotic drugs to make
safety-related changes to prescribing information, or labeling, to
warn about an increased risk of death associated with the off-label

OB/GYN News - Atypical antipsychotics

Friday, December 5th, 2008

The reproductive safety of the older typical antipsychotics, such as haloperidol, is supported by extensive data that have accumulated over the past 40 years, at least with respect to teratogenic risk. Much of the data come from their use in treating nausea, particularly with prochlorperazine (Compazine). While…